![EHRAPresident on X: "14/24 Well-known: oral #anticoagulation should be considered if CHA2DS2-VASc ≥1 in males and ≥2 in females. In patients with #AFib initially at low risk of stroke, first reassessment of EHRAPresident on X: "14/24 Well-known: oral #anticoagulation should be considered if CHA2DS2-VASc ≥1 in males and ≥2 in females. In patients with #AFib initially at low risk of stroke, first reassessment of](https://pbs.twimg.com/media/ElPNWqDWMAAsQB-.jpg:large)
EHRAPresident on X: "14/24 Well-known: oral #anticoagulation should be considered if CHA2DS2-VASc ≥1 in males and ≥2 in females. In patients with #AFib initially at low risk of stroke, first reassessment of
![Atrial Fibrillation: An Approach to Diagnosis and Management in the Emergency Department | Calculated Decisions Atrial Fibrillation: An Approach to Diagnosis and Management in the Emergency Department | Calculated Decisions](https://www.ebmedicine.net/media_library/images/MDCalc/CHA2DS2.png)
Atrial Fibrillation: An Approach to Diagnosis and Management in the Emergency Department | Calculated Decisions
![Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk](https://www.ahajournals.org/cms/asset/f0c76a4b-279a-46cf-abea-39dfbbb036a3/e003476fig02.jpeg)
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk
![Stroke Risk Factors Beyond the CHA2DS2-VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? - ScienceDirect Stroke Risk Factors Beyond the CHA2DS2-VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002914915019359-gr1.jpg)
Stroke Risk Factors Beyond the CHA2DS2-VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? - ScienceDirect
![PDF] Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score | Semantic Scholar PDF] Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/701606b6f7d086fe6e65e93f9961d5ae9ad858bb/2-Table1-1.png)
PDF] Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score | Semantic Scholar
![Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología](https://static.elsevier.es/multimedia/18855857/0000006700000005/v2_201404301330/S1885585714000875/v1_201404301330/en/main.assets/gr1.jpeg)
Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología
![Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1a84262bf2416f30f2c400e67d530b3957f84ba5/3-Table2-1.png)
Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar
![Full article: Anticoagulation for atrial fibrillation patients with the CHA2DS2-VASc score =1 (beyond sex) Full article: Anticoagulation for atrial fibrillation patients with the CHA2DS2-VASc score =1 (beyond sex)](https://www.tandfonline.com/cms/asset/91626976-4ea2-46bf-913f-7d9870f96617/tacd_a_1720197_f0001_b.jpg)
Full article: Anticoagulation for atrial fibrillation patients with the CHA2DS2-VASc score =1 (beyond sex)
Young Male Patients with Atrial Fibrillation and CHA2DS2-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based Study | PLOS ONE
![A schematic representation showing the strategy of anticoagulant use... | Download Scientific Diagram A schematic representation showing the strategy of anticoagulant use... | Download Scientific Diagram](https://www.researchgate.net/publication/257731952/figure/fig4/AS:669051147796487@1536525632448/A-schematic-representation-showing-the-strategy-of-anticoagulant-use-according-to-CHADS2.png)
A schematic representation showing the strategy of anticoagulant use... | Download Scientific Diagram
![Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem? Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?](https://www.escardio.org/static-file/Escardio/Medias/councils/council-for-cardiology-practice/news/Figure%201.%20Decision%20tree%20for%20oral%20anticoagulation%20in%20patients%20with%20atrial%20fibrillation.jpg?mts=1592578501000.jpg)
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?
![Case Clinic: A 67-Year-Old White Male Patient With Atrial Fibrillation Risk Factors- Clinical Advisor Case Clinic: A 67-Year-Old White Male Patient With Atrial Fibrillation Risk Factors- Clinical Advisor](https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/04/Table-1.jpg)
Case Clinic: A 67-Year-Old White Male Patient With Atrial Fibrillation Risk Factors- Clinical Advisor
![IJERPH | Free Full-Text | Anticoagulant Treatment in Patients with AF and Very High Thromboembolic Risk in the Era before and after the Introduction of NOAC: Observation at a Polish Reference Centre IJERPH | Free Full-Text | Anticoagulant Treatment in Patients with AF and Very High Thromboembolic Risk in the Era before and after the Introduction of NOAC: Observation at a Polish Reference Centre](https://www.mdpi.com/ijerph/ijerph-20-06145/article_deploy/html/images/ijerph-20-06145-g001.png)
IJERPH | Free Full-Text | Anticoagulant Treatment in Patients with AF and Very High Thromboembolic Risk in the Era before and after the Introduction of NOAC: Observation at a Polish Reference Centre
![Figure 1 from Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? | Semantic Scholar Figure 1 from Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/63e7ef97ef5bd0f249c299f7ec378b723dd0ce17/3-Figure1-1.png)